Version:

02-04-2014 01-06-2015 01-01-2017: Launch of the 2017 national vaccination programme 27-09-2020: 2020 National Vaccination Plan published 25-06-2025: Version 2025

Footnotes:

1. https://www.sns.gov.pt/vacinacao-gripe-e-covid-19-outono-inverno-2023/
2. PCV 13 included at 2, 4 and 12 months old (for children born after 1 January 2015)
3. People 6 months-17 years of age with severe and moderate immunosuppression conditions..https://www.sns24.gov.pt/pt/tema/vacinas/vacinacao-gripe-e-covid-19/
4. For more information: https://www.sns24.gov.pt/pt/tema/vacinas/vacinacao-gripe-e-covid-19/
5. Adult Td booster at ages 25, 45 and 65, thereafter every 10 years. Tdap vaccination recommended during pregnancy between 20 to 36 weeks of gestation
6. Tdap vaccination recommended during pregnancy in all ages between 20 to 36 weeks of gestation
7. 9-valent. Two-dose schedule at 0 and 6 months. Applicable to boys born from 2009.
8. Individuals can start vaccination up to the age of 17 and complete it up to the age of 26.
9. QIV-HD is funded for people aged 85 years and older. More information: https://www.dgs.pt/normas-orientacoes-e-informacoes/normas-e-circulares-normativas/norma-n-072024-de-04092024-atualizada-a-07032025-campanha-de-vacinacao-sazonal-contra-a-gripe-outono-inverno-2024-2025-.aspx

More information available at:
https://www.dgs.pt/paginas-de-sistema/saude-de-a-a-z/programa-nacional-de-vacinacao/programa-nacional-de-vacinacao.aspx https://www.dgs.pt/ficheiros-de-upload-2013/pnv-esquema-recomendado-pdf11.aspx https://www.dgs.pt/normas-orientacoes-e-informacoes/normas-e-circulares-normativas/norma-n-0182020-de-27092020-pdf.aspx https://www.sns24.gov.pt/tema/vacinas/programa-nacional-de-vacinacao/


MAJOR HISTORICAL CHANGES

Jan.2017: laucnh of the 2017 national vaccination programme. see modifications at http://www.dgs.pt/?ci=923&ur=1&newsletter=374

BCG:
2017: recommended only to specific risk-groups. previously universal vaccination

Measles, mumps and rubella:
1973-77: Vaccination campaign with measles monovalent vaccine to 1-4 years old children.
1974: Measles monovalent vaccine introduced in the national childhood vaccination programme and recommended at 12 to 24 months of age.
1987: Combined measles, mumps and rubella vaccine (MMR) introduced in the national childhood vaccination programme and recommended at 15 months of age.
1990: Second MMR dose added and recommended at 11-13 years of age.
2000: Recommended age for second MMR lowered to 5-6 years of age.
2012: First dose lowered to 12 months of age

HPV:
2008: 27 October. HPV vaccination introduced in national vaccination schedule for 13-year-old girls.
2009: January. HPV vaccination catch-up campaign lasting till 2011, for 17-year old girls.
2012: routine vaccination at 13 years.
2014: HPV schedule changed to 2 doses at 10-13 years old (since oct 2014)
2017: HPV nonavalent introduced as a 2 doses schedule for females at age 10
2020: vaccination extended to boys born from 2009

Meningococcal disease
Men C:
2012: one dose at 12 months instead of a 3-dose schedule

Men B:
2020: introduced as a 3-dose schedule for children born from 2019

Pneumococcal Disease:
2015: PCV 13 included at 2, 4 and 12 months old (since jul 2015)

Td: Adult booster
2017: Vaccination at 25, 45 and 65 years of age and thereafter every 10 years

TdaP: Vaccination during pregnancy
2017: to be given at each pregnancy between gestation week 20 to 36.



Vaccination for specific at-risk groups:
Children
- Rotavirus vaccination is recommended for children with some chronic conditions
- Tetravalent Men vaccination is recommended for selected groups
- Hep A vaccination is recommended for selected groups.

Adults
- PCV and PPSV23 for adults (>=18 years old) with certain chronic conditions (https://www.dgs.pt/normas-orientacoes-e-informacoes/normas-e-circulares-normativas/norma-n-0112015-de-23062015-pdf.aspx)


________________________________________________________________________

Date of last update: 22 Jan. 2024

________________________________________________________________________